Softgel Capsules Market Share, Size, Trends and Growth
The global softgel capsules market stood at USD 6.52 billion in 2020. The rising launch of vegan
products by numerous renowned companies across the globe is set to affect
growth positively. As these are 100% and do not have any potential health risk,
their demand is surging rapidly. For instance, in November 2020, Aenova
unveiled its latest vegan soft capsules called VegaGels. They conform to the
Chinese, E.U., and U.S. regulatory specifications. This
information is given by Fortune
Business Insights™ in a new study, titled, “Softgel Capsules Market, 2021-2027.” As per the study, the market size
is projected to grow from USD 6.94 billion in
2021 to USD 9.59 billion in 2027 at a CAGR of 5.5% in the forecast period.
For more
Information: https://www.fortunebusinessinsights.com/softgel-capsules-market-103353
Surging Demand for Vitamins to
Avoid Transmission of COVID-19 will Favor Growth
The
COVID-19 pandemic has severely affected the supply chain of numerous companies
worldwide, thereby impacting the healthcare sector. But, it has showcased a
positive effect on the softgel capsules industry because of the high demand
for diet supplements and vitamins
to prevent transmission of the coronavirus. We are offering accurate research
reports to help you better understand the current situation.
A list of prominent softgel capsules manufacturers operating in the
global market:
·
Capsugel (Lonza) (New Jersey, U.S.)
·
Sirio Pharma Co., Ltd. (Guangdong, China)
·
Catalent, Inc (New Jersey, U.S.)
·
Aenova Holding GmbH (Munich, Germany)
·
Fuji Capsule Co., Ltd. (Shizuoka, Japan)
·
CAPTEK Softgel International Inc. (California, U.S.)
·
Curtis Health Caps (Wielkopolskie, Poland)
·
EuroCaps Ltd (South Wales, UK)
·
Other prominent players
Comments
Post a Comment